MSTU:BATS-T-REX 2X Long MSTR Daily Target ETF (USD)

ETF | Others |

Last Closing

USD 5.16

Change

-1.24 (-19.38)%

Market Cap

USD 1.38B

Volume

0.07B

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
FBTC Fidelity Wise Origin Bitcoin T..

+4.89 (+7.30%)

USD 16.57B
INDA iShares MSCI India ETF

+2.06 (+4.19%)

USD 8.63B
PAVE Global X U.S. Infrastructure D..

+3.18 (+9.41%)

USD 7.86B
BUFR First Trust Cboe Vest Fund of ..

+1.45 (+5.31%)

USD 6.45B
BOXX Alpha Architect 1-3 Month Box ..

+0.04 (+0.04%)

USD 5.42B
BBUS JPMorgan BetaBuilders U.S. Equ..

+8.49 (+9.47%)

USD 4.20B
ARKB ARK 21Shares Bitcoin ETF

+5.52 (+7.21%)

USD 4.01B
KNG FT Cboe Vest S&P 500® Dividen..

+2.39 (+5.28%)

USD 3.66B
GSUS Goldman Sachs MarketBeta US Eq..

+6.55 (+9.59%)

USD 2.47B
IFRA iShares U.S. Infrastructure ET..

+2.58 (+6.30%)

USD 2.19B

ETFs Containing MSTU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -32.11% 3% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -32.11% 3% F 2% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 1.38B 97% N/A 93% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike